HLA-C and type 1 diabetes mellitus: In the next generation of studies, GWAS may be used to map genomic regions other than the MHC genes that contribute to the susceptibility of humans to T1D [77], which could lead to the creation of more genetically modified NOD mouse models to explore T1D genotype-phenotype relationships.